Huge news for Peptide enthusiasts BPC-157 passed an FDA advisory panel vote and is one step closer to allowing pharmacy compounding Aside from GLP1s, this is probably the peptide that can help the most people with its efficacy in injury recovery and gut health Huge news for Peptide enthusiasts BPC-157 passed an FDA advisory panel vote and is one step closer to allowing pharmacy compounding Aside from GLP1s, this is probably the peptide that can help the most people with its efficacy in injury recovery and gut health pharmacy compounding is the unlock compounding is the real unlock, grey market BPC was always sketchy finally no more sketch sourcing Join the conversation
No consistent associations were observed for increased smoking behavior after multivariable adjustment for the remaining covariates
If they arent losing weight on drug A, they can move on to drug B or C
Beyond that, it is designed to identify its source through: Detailed medical history Dr Aaron Poh will review stool appearance, duration, medications, supplements and associated symptoms such as dizziness or fatigue
With that context in mind, here are some of the reasons a provider may consider a lower starting dose for certain individuals
